Good post. Well thought out. Thanks for sharing.
Post# of 30028
Posted On: 01/05/2015 10:38:47 PM
Good post. Well thought out. Thanks for sharing.
I think the company has a clue or they wasted a lot of time and resources. The "If You Build It He Will Come" approach usually isn't a good business model and the BOD would know that.
Quote:
no one has a gosh darn clue whether Lympro "works well enough" to be the new standard diagnostic.
I think the company has a clue or they wasted a lot of time and resources. The "If You Build It He Will Come" approach usually isn't a good business model and the BOD would know that.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼